SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
TB and Other Coinfections
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
5 of
5
|
A Phase 2 Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment
Susan E. Dorman
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
Tuberculosis Infection in Early Childhood in Uganda and the Influence of HIV Exposure
Carina Marquez
University of California, San Francisco, San Francisco, CA, United States
Effect of Xpert MTB/RIF On Early Mortality in Adults With Suspected TB: A Pragmatic Randomized Trial
Gavin Churchyard
Aurum Institute, Houghton, South Africa
Xpert as the First-Line TB Test in South Africa: Yield, Initial Loss To Follow-Up, Proportion Treated
Katherine L. Fielding
London School of Hygiene & Tropical Medicine, London, United Kingdom
14 Day EBA Study of PA-824, Bedaquiline, Pyrazinamide and Clofazimine in Smear-Positive TB Patients
Andreas Diacon
Department of Medical Biochemistry, Stellenbosch University, Cape Town, South Africa
CTX Prophylaxis Discontinuation Among ART-Treated Adults: A Randomized Non-Inferiority Trial
Christina S. Polyak
Military HIV Research Program, Walter Reed Army Institute of Research, University of Washington, Bethesda, MD, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
5 of
5
|
